ArticleFrontiers in neurology2026

Correction: Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis.

Pietro Annovazzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.